A published scientist and inventor, with multiple peer-reviewed publications and patents in genetics and drug development, Dr. Mah most recently served as a Senior Research Analyst at TD Securities, where his work was concentrated on emerging life science tools and diagnostic technologies. Dr. Mah brings more than two decades of experience spanning finance and scientific research. His financial experience spans equity research and health care investment banking, advising both public and private companies on strategic growth and partnerships. Dr. Mah holds a B.S. in molecular biology from the University of California, Los Angeles; a Ph.D. in molecular biology from the University of California, San Diego; and an MBA from Cornell University’s Johnson Graduate School of Management.
